9.27.19
8 min. Read

Trouble in Pear-adise? More details on ESI’s digital formulary.

Issue 021.

Get E&O weekly. | Subscribe| Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a balmy 70 percent open rate. Here's what's happening this week:

  • I spent the past few days at the Boston-based DTx East conference, which was squarely focused on all things digital therapeutics. The event had a handful of standout panels and presos on-stage, but -- as always -- the conversations between sessions proved more informative. Scroll down for my initial writeups, and I'll relay more from the event in next week's note.
  • You likely saw this already but here are quick links for the four FDA guidance documents (updates and mulligans) that the agency posted this week. Their publication coincides with AdvaMed's big MedTech conference. Just so you have the links handy: Here's the updated guidance on mobile medical apps, the updated (after 20 years) guidance on

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Better Therapeutics shuts down. Mahana-Cara Care
3.18.24
5 min. Read
HCPCS and CPT decisions. Akili results. Click trials
3.08.24
7 min. Read
De Novo: Samsung Galaxy Watch gets OTC sleep apnea detection
2.16.24
7 min. Read
Facebook’s RCT for AI bot Zenny. More trials
1.30.24
7 min. Read
FDA de novo for Google smartphone thermometer.
1.05.24
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
12.15.23
8 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
12.01.23
6 min. Read
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
11.16.23
8 min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
11.06.23
6 min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
10.27.23
5 min. Read
  • First
  • Previous
  • 1 of 20
  • Next
  • Last